Navigation Links
Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
Date:4/17/2008

April 16, 2008 -- Ezra Susser, MD, DrPH, Anna Cheskis Gelman and Murray Charles Gelman Professor and chair of the Department of Epidemiology at the Mailman School of Public Health and professor of Psychiatry, College of Physicians and Surgeons, was awarded the 2008 Distinguished Investigator Award from NARSAD, the world's leading nonprofit organization dedicated to mental health research. Dr. Susser was selected for a study on famine and the genetics of schizophrenia taking place in China. The $100,000 award will allow Dr. Susser and an international team of researchers including Mary Claire King (University of Washington School of Medicine), David St. Clair (University of Aberdeen) and Lin He (Shanghai Jiao Tong University, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences) to continue their research on the hypothesis that prenatal exposure to maternal famine increases subsequent risk of schizophrenia, and to better understand the genetic mechanisms underlying this disorder.

The scientists are looking at genetic mutations among persons in China exposed in utero to the 1959-1960 famine and are collecting diagnostic data and DNA samples to evaluate these variations. Although the initial sample will include about 60 individuals diagnosed with schizophrenia and their relatives, the research group is also planning for additional funding to assess a much larger sample and appropriate control groups.

In an August 2006 paper published in the Journal of the American Medical Association (JAMA), Dr. Susser and coauthors, Mary-Claire King and Jack McClellan, discussed how persons conceived during the height of two 20th Century famines experienced increased risk of schizophrenia, compared with unexposed persons, and new developments in uncovering the possible genetic bases. Concurrent to this work, Dr. Susser oversees a series of studies in the United States, known as the Prenatal Determinants of Schizophrenia (PDS), which is conne
'/>"/>

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
2. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
3. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
4. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
5. African medical research and training receives Wellcome boost
6. Sen. Robert Byrd Receives AOA Health Care Leadership Award
7. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
8. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
9. OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
10. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
11. iCAD Receives FDA Approval for Its SecondLook Digital for Use With Fujis Digital Mammography System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...LEM, N.C. A study out of Wake Forest University B...doctors are correctly identifying patients who are... haven,t yet confirmed it. , The study used data...ents with heart attack symptoms who were admitted ...ing U.S. centers. , The findings were released ...
(Date:7/23/2008)...red Problem For 10+ Years Even Though Some Kilns E... on Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY...wswire-USNewswire/ -- For more than a decade,after...ion from cement,kilns across the nation, the U.S. ...ake action. Now, a new study from Earthjustice and...
(Date:7/23/2008)...n DC - July 23, 2008) Biodiversity has long been r...l-being. Humans rely on healthy ecosystems to pro...s understood is the connection between disease and...d animals found in a geographic region). Recent s...rotect us against diseases such as Lyme disease an...
(Date:7/23/2008)...S, July 23 /PRNewswire/ -- Mercy Health Plans, the...y founded in 1994 by the,Sisters of Mercy Health S...s Medicare Advantage plans to: Mercy MedicareAdvan...t. Louis, Illinois and Southwest Missouri,previou...ierPlus Options,St. John,s PremierPlus and St. Jo...
Breaking Medicine News(10 mins):Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7Health News:Could preserving biodiversity reduce disease? 2
...cited scientists, even after twenty years of its i...me the evil ways of viruses, such as those involve...e (HIV). Scientists have realized there is one stu...ways towards the development of an effective trans...
...amme has been planned in Edmonton’s Capital Health... level of a person is recorded whenever he or she ...ediately stored in a central database. This inform...etes and treat the illness if found. If diabetes ...
...ertension means high pressure in the arteries. Hig... ‘ silent killer’ because one can have it for year...rmal BP when his blood pressure reading is around ...e with systolic reading between 130 and 139, and a...
...e's pharmaceutical giant, is finalizing its plan o...rix against Merck & Co.'s Gardasil, in a bid to es...l cancer. The study, which will be conducted in t...e the immune responses of women aged 18 to 26 year...
Other Medicine News:Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 2Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 3Health News:Slightly High Blood Pressure is Also Hazardous 2
(Date:7/22/2008)...swire-FirstCall/ -- Following a,thorough review th...harmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) to...hase 3 study in liver cancer. Progen confirmed,its...olio of compounds and,the company will actively se...es through Merger & Acquisition activity., The st...
(Date:7/22/2008)...nt Plan Completed Successfully, DUBLIN, Ireland, ...on,plc (NASDAQ: AMRN ) today announced that the C...d and Drug Administration (FDA) to discuss the,Com...f,hypertriglyceridemia. Following these discussion...1 in hypertriglyceridemia., Dr. Declan Doogan, He...
(Date:7/22/2008)...mportance to Patients of Passing a ... Va., July 22 /- Insmed Inc...gics and biopharmaceuticals, today,announced that ... at a,Congressional briefing on Friday, July 25th,...hing an approval pathway for follow-on,biologics (...
(Date:7/22/2008)...polysis Technology in the European .../- Cynosure, Inc.,(Nasdaq: ... broad array of,light-based aesthetic treatment sy...lipo MPX(TM), the company,s high-powered, dual-wav...ighten skin through collagen,remodeling. The CE Ma...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 1A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 2Quality of Life Predicts Lung Cancer Survival 5015 1Quality of Life Predicts Lung Cancer Survival 5015 2American College of Physicians publishes 26quot 3BPeripheral Arterial Disease 26quot 3B 5013 1Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 1Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 2
...r for U.S. Trial -, MISSISSAUGA, ON, July 11, 2007... oncology company that identifies, develops,and co...worldwide,today announced results of secondary en...bo-controlled, multi-center Phase IIb,trial (DLXLE...inhaled-delivery composition of free and liposome-...
... American Heart Journal , ,WINNIPEG, Manitoba - (...a cardiovascular focused, biopharmaceutical compan...sults from the,STRATEGY (Single High-Dose Bolus Ti...ab and Bare Metal Stent In Acute Myocardial,Infarc...the Journal,of the American College of Cardiology ...
Other Medicine Technology:YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 2YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 3YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 5Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5
Operating Microscope with excellent maneuverability. Konan made it compact and light weight maintaining high quality. Easy switchover from straight to oblique by simply changing the adapter. Konan's
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure.
With side bite Instrument recommended to catch the polypropylene thread in the nose.
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems.
Medicine Products: